{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:15:38Z","timestamp":1761178538806,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Salah Azaiez Institute, Tunis, Tunisia"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.canrad.2020.01.004","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T12:45:35Z","timestamp":1583930735000},"page":"206-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study"],"prefix":"10.1016","volume":"24","author":[{"given":"I.","family":"Zawati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Adouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Finetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma.","family":"Manai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Manai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gamoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bertucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mezlini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2020.01.004_bib0155","doi-asserted-by":"crossref","first-page":"12971","DOI":"10.18632\/oncotarget.24191","article-title":"CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma","volume":"9","author":"Hanauer","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.canrad.2020.01.004_bib0160","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bulcan.2018.04.001","article-title":"[Tunisian National Protocol for Adult Hodgkin's Lymphoma Treatment: Results of a therapeutic regimen adapted to the 2-cycle CT response, about 444 patients]","volume":"105","author":"Ben Lakhal","year":"2018","journal-title":"Bull Cancer"},{"key":"10.1016\/j.canrad.2020.01.004_bib0165","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrclinonc.2015.92","article-title":"Adolescent and young adult patients with cancer: a milieu of unique features","volume":"12","author":"Sender","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.canrad.2020.01.004_bib0170","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S1470-2045(16)00162-5","article-title":"Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5","volume":"17","author":"Trama","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2020.01.004_bib0175","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000360205","article-title":"The challenging aspects of managing adolescents and young adults with Hodgkin's lymphoma","volume":"132","author":"Jachimowicz","year":"2014","journal-title":"Acta Haematol"},{"key":"10.1016\/j.canrad.2020.01.004_bib0180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12185-018-2449-8","article-title":"Clinical characteristics and outcomes of diffuse large B-cell lymphoma in adolescents and young adults","volume":"108","author":"Suzuki","year":"2018","journal-title":"Int J Hematol"},{"key":"10.1016\/j.canrad.2020.01.004_bib0185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cncr.30979","article-title":"Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis","volume":"124","author":"Henderson","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2020.01.004_bib0190","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/bjh.13903","article-title":"Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood\/Adolescent\/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer","volume":"172","author":"Bhuller","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.canrad.2020.01.004_bib0195","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2018-01-778548","article-title":"The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice?","volume":"132","author":"Flerlage","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2020.01.004_bib0200","doi-asserted-by":"crossref","first-page":"80073","DOI":"10.18632\/oncotarget.20684","article-title":"Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients","volume":"8","author":"Bigenwald","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canrad.2020.01.004_bib0205","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1200\/JCO.2008.20.2655","article-title":"Hodgkin's lymphoma in adolescents treated with adult protocols: a report from the German Hodgkin Study Group","volume":"27","author":"Eichenauer","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.01.004_bib0210","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2020.01.004_bib0215","first-page":"1598","article-title":"Cotswolds modification of the Ann Arbor staging system for Hodgkin's disease","volume":"8","author":"Olweny","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.01.004_bib0220","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3324\/haematol.2012.072090","article-title":"Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant","volume":"98","author":"Van Den Neste","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.canrad.2020.01.004_bib0225","first-page":"64","article-title":"Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report","author":"Fern\u00e1ndez","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.canrad.2020.01.004_bib0230","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/cncr.31953","article-title":"Use of recommended posttreatment services for adolescent and young adult survivors of Hodgkin lymphoma","volume":"125","author":"Hahn","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2020.01.004_bib0235","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjh.15789","article-title":"Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non-Hodgkin and Hodgkin ymphoma","volume":"185","author":"Metzger","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.canrad.2020.01.004_bib0240","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/cncr.22102","article-title":"Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials","volume":"107","author":"Bleyer","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2020.01.004_bib0245","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.2006.08.1331","article-title":"Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte","volume":"25","author":"Casasnovas","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.01.004_bib0250","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2005.11.080","article-title":"Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study group","volume":"23","author":"Engert","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.01.004_bib0255","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1182\/blood-2011-09-378414","article-title":"A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era","volume":"119","author":"Evens","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2020.01.004_bib0260","first-page":"251","article-title":"Patterns of Hodgkin's disease at diagnosis in young children","volume":"5","author":"White","year":"1983","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.canrad.2020.01.004_bib0265","doi-asserted-by":"crossref","first-page":"67551","DOI":"10.18632\/oncotarget.11509","article-title":"Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine","volume":"7","author":"Nagpal","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canrad.2020.01.004_bib0270","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM198903163201103","article-title":"Hodgkin's disease and Epstein-Barr virus Altered antibody pattern before diagnosis","volume":"320","author":"Mueller","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2020.01.004_bib0275","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2005.04.5823","article-title":"Hodgkin's lymphoma in adolescents","volume":"24","author":"Foltz","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.01.004_bib0280","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1080\/1042819042000209404","article-title":"Long term outcome in adolescents with Hodgkin's lymphoma: poor results using regimens designed for adults","volume":"45","author":"Yung","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.canrad.2020.01.004_bib0285","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1002\/cncr.27684","article-title":"Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults","volume":"118","author":"Smith","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2020.01.004_bib0290","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2010.29.8018","article-title":"Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Stud*group HD11 trial","volume":"28","author":"Eich","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.01.004_bib0295","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2017-10-772665","article-title":"Balancing risk and benefit in early-stage classical Hodgkin lymphoma","volume":"131","author":"Br\u00f6ckelmann","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2020.01.004_bib0300","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.canrad.2018.05.002","article-title":"Anti-PD-1 immunotherapy in combination with sequential involved-site radiotherapy in heavily pretreated refractory Hodgkin lymphoma","volume":"23","author":"Qu\u00e9ro","year":"2019","journal-title":"Cancer Radiother"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820300494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820300494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:31:41Z","timestamp":1761136301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321820300494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1278321820300494"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2020.01.004","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2020.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}